IBDEI363 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,53178,1,3,0)
 ;;=3^Lichen Sclerosus et Atrophicus
 ;;^UTILITY(U,$J,358.3,53178,1,4,0)
 ;;=4^L90.0
 ;;^UTILITY(U,$J,358.3,53178,2)
 ;;=^70699
 ;;^UTILITY(U,$J,358.3,53179,0)
 ;;=L28.0^^243^2668^5
 ;;^UTILITY(U,$J,358.3,53179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53179,1,3,0)
 ;;=3^Lichen Simplex Chronicus
 ;;^UTILITY(U,$J,358.3,53179,1,4,0)
 ;;=4^L28.0
 ;;^UTILITY(U,$J,358.3,53179,2)
 ;;=^259859
 ;;^UTILITY(U,$J,358.3,53180,0)
 ;;=L66.1^^243^2668^1
 ;;^UTILITY(U,$J,358.3,53180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53180,1,3,0)
 ;;=3^Lichen Planopilaris
 ;;^UTILITY(U,$J,358.3,53180,1,4,0)
 ;;=4^L66.1
 ;;^UTILITY(U,$J,358.3,53180,2)
 ;;=^5009253
 ;;^UTILITY(U,$J,358.3,53181,0)
 ;;=L43.0^^243^2668^2
 ;;^UTILITY(U,$J,358.3,53181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53181,1,3,0)
 ;;=3^Lichen Planus,Hypertrophic
 ;;^UTILITY(U,$J,358.3,53181,1,4,0)
 ;;=4^L43.0
 ;;^UTILITY(U,$J,358.3,53181,2)
 ;;=^5009178
 ;;^UTILITY(U,$J,358.3,53182,0)
 ;;=L43.2^^243^2668^6
 ;;^UTILITY(U,$J,358.3,53182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53182,1,3,0)
 ;;=3^Lichenoid Drug Reaction
 ;;^UTILITY(U,$J,358.3,53182,1,4,0)
 ;;=4^L43.2
 ;;^UTILITY(U,$J,358.3,53182,2)
 ;;=^5009180
 ;;^UTILITY(U,$J,358.3,53183,0)
 ;;=L43.9^^243^2668^3
 ;;^UTILITY(U,$J,358.3,53183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53183,1,3,0)
 ;;=3^Lichen Planus,Unspec
 ;;^UTILITY(U,$J,358.3,53183,1,4,0)
 ;;=4^L43.9
 ;;^UTILITY(U,$J,358.3,53183,2)
 ;;=^5009183
 ;;^UTILITY(U,$J,358.3,53184,0)
 ;;=L93.0^^243^2668^8
 ;;^UTILITY(U,$J,358.3,53184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53184,1,3,0)
 ;;=3^Lupus,Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,53184,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,53184,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,53185,0)
 ;;=L93.2^^243^2668^10
 ;;^UTILITY(U,$J,358.3,53185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53185,1,3,0)
 ;;=3^Lupus,Erythematosus,Local
 ;;^UTILITY(U,$J,358.3,53185,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,53185,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,53186,0)
 ;;=L93.1^^243^2668^11
 ;;^UTILITY(U,$J,358.3,53186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53186,1,3,0)
 ;;=3^Lupus,Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,53186,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,53186,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,53187,0)
 ;;=M32.0^^243^2668^9
 ;;^UTILITY(U,$J,358.3,53187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53187,1,3,0)
 ;;=3^Lupus,Erythematosus,Drug-Induced Systemic
 ;;^UTILITY(U,$J,358.3,53187,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,53187,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,53188,0)
 ;;=M32.10^^243^2668^12
 ;;^UTILITY(U,$J,358.3,53188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53188,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic
 ;;^UTILITY(U,$J,358.3,53188,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,53188,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,53189,0)
 ;;=M32.19^^243^2668^14
 ;;^UTILITY(U,$J,358.3,53189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53189,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
 ;;^UTILITY(U,$J,358.3,53189,1,4,0)
 ;;=4^M32.19
 ;;^UTILITY(U,$J,358.3,53189,2)
 ;;=^5011759
 ;;^UTILITY(U,$J,358.3,53190,0)
 ;;=M32.9^^243^2668^13
 ;;^UTILITY(U,$J,358.3,53190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53190,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
 ;;^UTILITY(U,$J,358.3,53190,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,53190,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,53191,0)
 ;;=E88.1^^243^2668^7
 ;;^UTILITY(U,$J,358.3,53191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53191,1,3,0)
 ;;=3^Lipodystrophy NOS
